Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Financial goals should evolve with life. This guide covers indicators that warrant updating targets and practical steps to realign your plan.
22,275 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
May 2026 data from the Federal Reserve show consumer credit contracted, ending a six-month gain. Analysts warn the pu...
Meta's AI model projects a substantial rally for gold and silver by end-2026, framing both as twin bets on a shared m...
As the three-year mark of the Ripple-SEC ruling arrives, XRP has moved from regulator target to institutional asset, ...
Adobe’s chief marketing officer is steering a bold pivot to AI-powered brand discovery, reshaping budgets, metrics, a...
As markets wobble in mid-2026, a trio of NYSE dividend names stands out for safety and income. They combine durable c...
A T-Rex fossil nicknamed Gus sold for $50.1 million at auction, setting a new price record and signaling renewed dema...
Strategy insists it isn’t retreating from its bitcoin holdings as it navigates debt risk thresholds tied to bitcoin’s...
As AI surges, regulators move faster than hype. Markets put odds of model access curbs at about 27.5% for 2026, reviv...
Global smartphone shipments declined 11% year-over-year in the second quarter of 2026, marking the steepest drop in 1...
US Treasuries are amplifying market selloffs, dragging Bitcoin lower as risk-off trades surge. Analysts say tradition...
As Berkshire transitions to Greg Abel, Warren Buffett’s final investment points to a return to era-defining brands. T...